BioLine RX Ltd (BLRX) — Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

BioLine RX Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (ILA4.99 Million) in capital expenditures (ILA18.00K). Check BioLine RX Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

ILA4.99 Million
ILA

Capital Expenditures

ILA18.00K
ILA

Data as of

Dec 2023
Most recent filing

BioLine RX Ltd Capital Reinvestment Ratio (2010–2010)

This chart tracks BioLine RX Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see BioLine RX Ltd (BLRX) cash flow conversion.

Annual Capital Reinvestment Ratio for BioLine RX Ltd (2010–2010)

Year-by-year Capital Reinvestment Ratio for BioLine RX Ltd from 2010 to 2010. See BLRX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (ILA) Capital Expenditures YoY Change
2010 0.06x ILA11.46 Million ILA660.94K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow